Document is current

Any future updates will be listed below

Thrombin mutant W215A/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis

Crossref DOI link: https://doi.org/10.1007/s11011-014-9558-8

Published Online: 2014-05-09

Published Print: 2015-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark